European Patent Office grants a patent on CDNF to Hermo Pharma

The European Patent Office has announced that it has granted a European patent to the CDNF neurotrophic factor to Hermo Pharma Ltd. The European patent extends Hermo Pharma's portfolio on the CDNF/MANF technologies as the company already holds US patent rights to CDNF.

5.10.2010